Latest papers

The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006.

Managing acute on chronic respiratory failure: a guide to non-invasive ventilation.

Preparing the dental office for medical emergencies.

In vivo pharmacological evaluation of compound 48/80-induced airways oedema by MRI.

Guidelines for the diagnosis and treatment of acute and subacute rhinosinusitis in children.

Emerging mucus regulating drugs in inflammatory and allergic lung disease.

Unknown risks of pharmacy-compounded drugs.

Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse.

Geographic differences in clinical characteristics and management of COPD: the EPOCA study.

[Recommended treatment of apnea in premature infants. A review based on literature and own experience].

Pharmacoeconomics in COPD: lessons for the future.

ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopy.

Minimizing variability of cascade impaction measurements in inhalers and nebulizers.

Low-tidal-volume ventilation.

Apneic preterms and methylxanthines: arousal deficits, sleep fragmentation and suppressed spontaneous movements.

Single-dose versus two-dose dexamethasone effects on lung inflammation and airway reactivity in meconium-instilled rabbits.

Potential of lung surfactant proteins, SP-A and SP-D, and mannan binding lectin for therapy and genetic predisposition to allergic and invasive aspergillosis.

Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?

FDA: cold medications risky for young children.